235 related articles for article (PubMed ID: 26381729)
1. Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease.
Zhang M; Ni Z; Zhou W; Qian J
J Biomed Sci; 2015 Sep; 22(1):75. PubMed ID: 26381729
[TBL] [Abstract][Full Text] [Related]
2. Brain natriuretic peptide is related to carotid plaques and predicts atherosclerosis in pre-dialysis patients with chronic kidney disease.
Zhou W; Ni Z; Yu Z; Shi B; Wang Q
Eur J Intern Med; 2012 Sep; 23(6):539-44. PubMed ID: 22863432
[TBL] [Abstract][Full Text] [Related]
3. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.
Tang X; Chen M; Zhang W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 38(6):553-9. PubMed ID: 23828708
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.
Yilmaz G; Ustundag S; Temizoz O; Sut N; Demir M; Ermis V; Sevinc C; Ustundag A
Clin Lab; 2015; 61(8):1061-70. PubMed ID: 26427152
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum osteocalcin levels and carotid intima-media thickness in Chinese postmenopausal women.
Yang R; Ma X; Dou J; Wang F; Luo Y; Li D; Zhu J; Bao Y; Jia W
Menopause; 2013 Nov; 20(11):1194-9. PubMed ID: 23571521
[TBL] [Abstract][Full Text] [Related]
6. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.
Valdivielso JM; Coll B; Martín-Ventura JL; Moreno JA; Egido J; Fernández E; Blanco-Colio LM
J Nephrol; 2013; 26(6):1105-13. PubMed ID: 23475462
[TBL] [Abstract][Full Text] [Related]
7. Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients.
Ng YM; Lim SK; Kang PS; Kadir KA; Tai MS
BMC Nephrol; 2016 Oct; 17(1):151. PubMed ID: 27756244
[TBL] [Abstract][Full Text] [Related]
8. Association of Mild-to-Moderate Reduction in Glomerular Filtration Rate with Subclinical Atherosclerosis in Postmenopausal Women.
Parv F; Beceanu A; Avram R; Timar RZ; Timar B; Gadalean F
J Womens Health (Larchmt); 2017 Nov; 26(11):1201-1213. PubMed ID: 28537783
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis.
Janda K; Krzanowski M; Chowaniec E; Kuśnierz-Cabala B; Dumnicka P; Kraśniak A; Podolec P; Sułowicz W
Pol Arch Med Wewn; 2013; 123(4):149-55. PubMed ID: 23535831
[TBL] [Abstract][Full Text] [Related]
10. Correlation between Carotid Intima-Media Thickness and Early-Stage Chronic Kidney Disease: Results from Asymptomatic Polyvascular Abnormalities in Community Study.
Wu Y; Hou J; Li J; Luo Y; Wu S
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):259-65. PubMed ID: 26500173
[TBL] [Abstract][Full Text] [Related]
11. [Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease].
Yang XB; Hou FF; Wu Q; Zhou H; Liu ZR; Yang Y; Zhang X
Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):342-6. PubMed ID: 16009002
[TBL] [Abstract][Full Text] [Related]
12. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction.
Hayashi M; Yasuda Y; Suzuki S; Tagaya M; Ito T; Kamada T; Yoshinaga M; Sugishita Y; Fujiwara W; Yokoi H; Ozaki Y; Izawa H
Heart Vessels; 2017 Mar; 32(3):279-286. PubMed ID: 27385024
[TBL] [Abstract][Full Text] [Related]
14. Carotid intima media thickness is independently associated with urinary sodium excretion in patients with chronic kidney disease.
Ustundag S; Yilmaz G; Sevinc C; Akpinar S; Temizoz O; Sut N; Ustundag A
Ren Fail; 2015; 37(8):1285-92. PubMed ID: 26333718
[TBL] [Abstract][Full Text] [Related]
15. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease.
Yadav AK; Banerjee D; Lal A; Jha V
Nephrology (Carlton); 2012 Aug; 17(6):575-81. PubMed ID: 22489804
[TBL] [Abstract][Full Text] [Related]
17. Chronic Kidney Disease and Carotid Atherosclerosis in Patients With Acute Stroke.
Yu FP; Zhao YC; Gu B; Hu J; Yang YY
Neurologist; 2015 Aug; 20(2):23-6. PubMed ID: 26280286
[TBL] [Abstract][Full Text] [Related]
18. Carotid intima-media thickness and atherosclerotic plaques are associated with renal function decline: a 14-year longitudinal population-based study.
Goepfert M; Ittermann T; Dörr M; Friedrich N; Völzke H; Dabers T; Felix SB; Schminke U; Stracke S; von Rheinbaben S
Nephrol Dial Transplant; 2023 Oct; 38(11):2598-2606. PubMed ID: 37222460
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease is associated with carotid atherosclerosis and symptomatic ischaemic stroke.
Kajitani N; Uchida HA; Suminoe I; Kakio Y; Kitagawa M; Sato H; Wada J
J Int Med Res; 2018 Sep; 46(9):3873-3883. PubMed ID: 29968487
[TBL] [Abstract][Full Text] [Related]
20. Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease.
Anguiano L; Riera M; Pascual J; Valdivielso JM; Barrios C; Betriu A; Clotet S; Mojal S; Fernández E; Soler MJ;
Atherosclerosis; 2016 Oct; 253():135-143. PubMed ID: 27615597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
